Who Owns Clinuvel Pharmaceuticals Stock?
NASDAQ: CUVLMiscellaneousMiscellaneousUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 0.00%
- Held by insiders
- 0.00%
- Institutional holders
- 0
- Institutions 0.0%
- Insiders 0.0%
- Public and other 100.0%
Who owns Clinuvel Pharmaceuticals stock?
Institutional investors own about 0.0% of Clinuvel Pharmaceuticals's shares, spread across 0 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.00% of CUVL.
Summary generated from market data by MetaCap's automated system. Methodology
Frequently asked questions
What percentage of Clinuvel Pharmaceuticals is owned by institutions?
Institutions own about 0.0% of CUVL shares and 0.0% of the public float.
How much of Clinuvel Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 0.00% of CUVL shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.